Mavis Agnes Kisakye: From Advocacy to Action Strengthening Care for Bleeding Disorders in Uganda
Mavis Agnes Kisakye, Health Officer, EVD Response at Uganda Red Cross Society, shared a post on LinkedIn:
”It is always nice to revisit the invaluable insights from our advocacy training facilitated by the Novo Nordisk Haemophilia Foundation (NNHF). These sessions continue to serve as a vital reference point for our team as we push harder than ever to meet our strategic goals for the bleeding disorders community in Uganda.
The captured moments reflect the heart of our mission, showing our members clearly highlighting the systemic challenges we face and the collective determination of the team to find sustainable solutions. It is particularly inspiring to see our youth taking the lead, standing up to support their peers and ensuring that the next generation of leaders is equipped with the tools to advocate for their own health and financial independence.
Advocacy is not just about identifying the problems but about the relentless pursuit of a roadmap that brings specialized care to every corner of the country. We remain committed to this journey, fueled by the knowledge shared during our training and the resilient spirit of the families we serve.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies